VOYA Investment Management’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $26.7K | Sell |
|
|||||
|
2024
Q4 | $48.2K | Sell |
|
|||||
|
2024
Q3 | $38.7K | Hold |
|
|||||
|
2024
Q2 | $64.4K | Buy |
|
|||||
|
2024
Q1 | $75.3K | Sell |
|
|||||
|
2023
Q4 | $330K | Buy |
|
|||||
|
2023
Q3 | $235K | Sell |
|
|||||
|
2023
Q2 | $2.12M | Buy |
|
|||||
|
2023
Q1 | $514K | Sell |
|
|||||
|
2022
Q4 | $634K | Sell |
|
|||||
|
2022
Q3 | $2.86M | Sell |
|
|||||
|
2022
Q2 | $2.18M | Buy |
|
|||||
|
2022
Q1 | $931K | Buy |
|
|||||
|
2021
Q4 | $1.08M | Sell |
|
|||||
|
2021
Q3 | $1.12M | Buy |
|
|||||
|
2021
Q2 | $946K | Buy |
|
|||||
|
2021
Q1 | $989K | Buy |
|
|||||
|
2020
Q4 | $822K | Buy |
|
|||||
|
2020
Q3 | $646K | Sell |
|
|||||
|
2020
Q2 | $634K | Sell |
|
|||||
|
2020
Q1 | $740K | Buy |
|
|||||
|
2019
Q4 | $808K | Buy |
|
|||||
|
2019
Q3 | $490K | Hold |
|
|||||
|
2019
Q2 | $534K | Buy |
|
|||||
|
2019
Q1 | $290K | Sell |
|
|||||
|
2018
Q4 | $201K | Buy |
|
|||||
|
2018
Q3 | $330K | Buy |
|
|||||
|
2018
Q2 | $260K | Buy |
|
|||||
|
2018
Q1 | $195K | Hold |
|
|||||
|
2017
Q4 | $155K | Hold |
|
|||||
|
2017
Q3 | $235K | Hold |
|
|||||
|
2017
Q2 | $253K | Buy |
|
|||||
|
2017
Q1 | $282K | Hold |
|
|||||
|
2016
Q4 | $375K | Hold |
|
|||||
|
2016
Q3 | $357 | Hold |
|
|||||
|
2016
Q2 | $225K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $210K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $327K | Buy |
|